BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26845637)

  • 41. Aggressive angiomyxoma: a clinicopathological and immunohistochemical study of 11 cases with long-term follow-up.
    van Roggen JF; van Unnik JA; Briaire-de Bruijn IH; Hogendoorn PC
    Virchows Arch; 2005 Feb; 446(2):157-63. PubMed ID: 15735978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics.
    Cheah AL; Billings SD; Goldblum JR; Carver P; Tanas MZ; Rubin BP
    Pathology; 2014 Aug; 46(5):389-95. PubMed ID: 24977739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
    Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
    Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
    Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
    Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study of four cases of extra-orbital giant cell angiofibroma with documentation of some unusual features.
    Thomas R; Banerjee SS; Eyden BP; Shanks JH; Bisset DL; Hunt R; Byers RJ; Oogarah P; Harris M
    Histopathology; 2001 Oct; 39(4):390-6. PubMed ID: 11683940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.
    Nakayama R; Miura Y; Ogino J; Susa M; Watanabe I; Horiuchi K; Anazawa U; Toyama Y; Morioka H; Mukai M; Hasegawa T
    Pathol Int; 2012 Dec; 62(12):823-6. PubMed ID: 23252872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathological characteristics of angiofibroma of soft tissue: report of three cases.
    Ma HJ; Huang HN; Li L; Chen S; Zhang RY
    Int J Clin Exp Pathol; 2018; 11(7):3777-3784. PubMed ID: 31949763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
    Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
    Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
    Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
    Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiomatoid fibrous histiocytoma: clinicopathological and molecular characterisation with emphasis on variant histomorphology.
    Kao YC; Lan J; Tai HC; Li CF; Liu KW; Tsai JW; Fang FM; Yu SC; Huang HY
    J Clin Pathol; 2014 Mar; 67(3):210-5. PubMed ID: 24043718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
    Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
    Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A rare case of congenital spindle cell rhabdomyosarcoma with TEAD1-NCOA2 fusion: A subset of spindle cell rhabdomyosarcoma with indolent behavior.
    Tan GZL; Saminathan SN; Chang KTE; Odoño EG; Kuick CH; Chen H; Lee VKM
    Pathol Int; 2020 Apr; 70(4):234-236. PubMed ID: 31999033
    [No Abstract]   [Full Text] [Related]  

  • 53. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.
    Noujaim J; Jones RL; Swansbury J; Gonzalez D; Benson C; Judson I; Fisher C; Thway K
    Br J Cancer; 2017 Feb; 116(5):669-678. PubMed ID: 28141799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel sarcoma with dual differentiation: clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma.
    Vergara-Lluri ME; Stohr BA; Puligandla B; Brenholz P; Horvai AE
    Am J Surg Pathol; 2012 Jul; 36(7):1093-8. PubMed ID: 22743288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-α expression in pulmonary adenofibromas.
    Fusco N; Guerini-Rocco E; Augello C; Terrasi A; Ercoli G; Fumagalli C; Vacirca D; Braidotti P; Parafioriti A; Jaconi M; Runza L; Ananthanarayanan V; Pagni F; Bosari S; Barberis M; Ferrero S
    Histopathology; 2017 May; 70(6):906-917. PubMed ID: 28072477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel NCOA2/3-rearranged low-grade fibroblastic spindle cell tumors: A report of five cases.
    Bakhshwin A; Armstrong SM; Duckworth LA; Stoehr R; Konishi E; Rubin BP; Fritchie KJ; Dickson BC; Agaimy A; Dermawan JK
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23203. PubMed ID: 37724942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
    Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M
    Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.